Skip to main content
1005-2017, 1003-2007, 1006-2024, 1006-2019, 1005-2016, 1005-2014
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_504960,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_504960_Interventional-Therapies-for-Acute-Pulmonary-Embolism.jsp,docTitle=Interventional Therapies for Acute Pulmonary Embolism,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality in the U.S.,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=Embolectomy, pulmonary embolism, thrombolytic therapy,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=10/11/2019 9:24 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=10/11/2019 9:19 PM,xWebsiteSection=professional:1463,dDocName=UCM_504960,dpAction=null,dRevLabel=4,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_504960.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=4,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=504960,dIsPrimary=1,dFileSize=16853,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1906261,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=10/11/2019 9:25 PM,xTrashDeleteLoc=null,dCreateDate=10/11/2019 9:24 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=10/04/2019 9:30 PM,xRobotParameter=,xCommunities=1005-2017, 1003-2007, 1006-2024, 1006-2019, 1005-2016, 1005-2014,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

Interventional Therapies for Acute Pulmonary Embolism

PulmonaryEmbolism_750x500
  • Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality in the U.S.
  • Treatment options for PE with hemodynamic instability (high-risk PE) include systemic thrombolysis, surgical embolectomy, interventional PE therapy, and/or mechanical circulatory support.
  • Data to support use of interventional devices for intermediate risk PE should come from randomized trials that evaluate traditional clinical outcomes and/or patient-centric, functional/quality of life (QOL) measures.

Read the full article in Circulation

Supporting Materials